CO4700344A1 - Vacuna polinucleotidica para bovinos por via intradermica - Google Patents

Vacuna polinucleotidica para bovinos por via intradermica

Info

Publication number
CO4700344A1
CO4700344A1 CO97040984A CO97040984A CO4700344A1 CO 4700344 A1 CO4700344 A1 CO 4700344A1 CO 97040984 A CO97040984 A CO 97040984A CO 97040984 A CO97040984 A CO 97040984A CO 4700344 A1 CO4700344 A1 CO 4700344A1
Authority
CO
Colombia
Prior art keywords
cattle
vaccine
polynucleotidic
immunogen
intradermic
Prior art date
Application number
CO97040984A
Other languages
English (en)
Inventor
Franciscus Antonius Maria Rijsewijk
Remco Siebren Schrijver
Oirschot Johannes Theodorus Van
Original Assignee
Merial Sas
Id Dlo Inst Of Animal Science Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas, Id Dlo Inst Of Animal Science Health filed Critical Merial Sas
Publication of CO4700344A1 publication Critical patent/CO4700344A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18541—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18543—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Fórmula de vacuna polinucleotídica destinada abovinos que comprende una cantidad eficaz por vía intradérmica de un plasmido que asocia una secuencia de ADN codificante para un inmunógeno de un agente patógeno bovino con un promotor que permite la expresión de este inmunógeno in vivo en las células de la piel, estando adaptada esta fórmula de vacuna a la administración intradérmica por un aparato de administración por chorro líquido.
CO97040984A 1996-07-19 1997-07-18 Vacuna polinucleotidica para bovinos por via intradermica CO4700344A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609402A FR2751228B1 (fr) 1996-07-19 1996-07-19 Vaccin polynucleotidique bovin pour voie intradermique

Publications (1)

Publication Number Publication Date
CO4700344A1 true CO4700344A1 (es) 1998-12-29

Family

ID=9494496

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97040984A CO4700344A1 (es) 1996-07-19 1997-07-18 Vacuna polinucleotidica para bovinos por via intradermica

Country Status (23)

Country Link
US (2) US6451770B1 (es)
EP (1) EP0918540B1 (es)
JP (1) JP2000515522A (es)
AP (1) AP9701045A0 (es)
AR (1) AR007863A1 (es)
AT (1) ATE224732T1 (es)
AU (1) AU722878B2 (es)
BR (1) BR9710498A (es)
CA (1) CA2261334C (es)
CO (1) CO4700344A1 (es)
CZ (1) CZ298216B6 (es)
DE (1) DE69715879T2 (es)
ES (1) ES2184122T3 (es)
FR (1) FR2751228B1 (es)
HU (1) HU224833B1 (es)
ID (1) ID19427A (es)
IL (1) IL127914A (es)
MA (1) MA24271A1 (es)
MX (1) MXPA99000684A (es)
NZ (1) NZ333752A (es)
PL (1) PL189184B1 (es)
WO (1) WO1998003196A1 (es)
ZA (1) ZA976285B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294338B2 (en) * 1996-07-19 2007-11-13 Merial Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7078388B2 (en) * 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
FR2804028B1 (fr) * 2000-01-21 2004-06-04 Merial Sas Vaccins adn ameliores pour animaux de rente
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
EP2390352A1 (en) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systems and methods for improving protein and milk production of dairy herds
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
US20050214316A1 (en) 2003-11-13 2005-09-29 Brown Thomas P Methods of characterizing infectious bursal disease virus
AU2005244673B2 (en) 2004-02-19 2009-12-10 The Governors Of The University Of Alberta Leptin promoter polymorphisms and uses thereof
CA2570156C (en) * 2004-06-04 2014-09-30 Merial Limited Needle-free administration of felv vaccines
ES2343270T3 (es) 2005-04-25 2010-07-27 Merial Ltd. Vacunas contra el virus nipah.
US8591457B2 (en) 2005-08-10 2013-11-26 Alza Corporation Method for making a needle-free jet injection drug delivery device
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
CA2629522A1 (en) 2005-11-14 2007-05-18 Merial Limited Gene therapy for renal failure
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
US20080274137A1 (en) * 2007-05-02 2008-11-06 Jean Christophe Francis Audonnet DNA plasmids having improved expression and stability
JP2010525812A (ja) 2007-05-02 2010-07-29 メリアル リミテッド 発現及び安定性が改善されたｄｎａプラスミド
MX2011005604A (es) 2008-11-28 2011-09-01 Merial Ltd Vacuna recombinante para influenza aviar y sus usos.
DK2414386T3 (en) 2009-04-03 2016-02-22 Merial Ltd Birds of vaccines with newcastle disease virus vectors
MX351643B (es) 2009-12-28 2017-10-23 Merial Ltd Antigeno ndv recombinante y usos del mismo.
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
BR112012023852B1 (pt) 2010-03-12 2020-11-10 Biolex Therapeutics vacinas recombinantes do vírus da língua azul e usos das mesmas
PL2611460T3 (pl) 2010-08-31 2017-02-28 Merial, Inc. Szczepionki przeciw herpeswirusom przenoszone z pomocą wirusa choroby newcastle
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
WO2012138789A2 (en) 2011-04-04 2012-10-11 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment
EP2694677A2 (en) 2011-04-04 2014-02-12 Netherland Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
WO2012145577A1 (en) 2011-04-20 2012-10-26 Merial Limited Adjuvanted rabies vaccine with improved viscosity profile
EP2701736A1 (en) 2011-04-25 2014-03-05 Advanced Bioscience Laboratories, Inc. Truncated hiv envelope proteins (env), methods and compositions related thereto
CA2837582C (en) 2011-05-27 2021-03-02 Merial Limited Genetic vaccines against hendra virus and nipah virus
ES2674439T3 (es) 2011-06-01 2018-06-29 Merial, Inc. Administración sin aguja de vacunas contra el VSRRP
LT2741740T (lt) 2011-08-12 2017-08-10 Merial, Inc. Biologinių produktų, ypatingai vakcinų, vakuuminis konservavimas
WO2013093629A2 (en) 2011-12-20 2013-06-27 Netherlands Cancer Institute Modular vaccines, methods and compositions related thereto
AR089995A1 (es) 2012-02-14 2014-10-01 Merial Ltd Vacunas de subunidades de rotavirus, metodos de preparacion y uso de las mismas
CN104203271B (zh) 2012-02-14 2017-08-25 梅里亚股份有限公司 表达狂犬病病毒和ox40蛋白的重组痘病毒载体及从其制造的疫苗
WO2013138776A1 (en) 2012-03-16 2013-09-19 Merial Limited Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
EP2861248B1 (en) 2012-06-13 2017-11-15 Merial, Inc. Reassortant btv and ahsv vaccines
WO2014164697A1 (en) 2013-03-12 2014-10-09 Merial Limited Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
AU2015343369B2 (en) 2014-11-03 2018-11-22 Georgia Tech Research Corporation Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
EA201890110A1 (ru) 2015-06-23 2018-05-31 Мериал, Инк. Рекомбинантные вирусные векторы, содержащие минорные белки prrsv, и способы их получения и применения
NZ740551A (en) 2015-08-20 2019-10-25 Boehringer Ingelheim Animal Health Usa Inc Fcv recombinant vaccines and uses thereof
MA43016A (fr) 2015-09-29 2018-08-08 Merial Inc Vaccins à particules pseudo-virales (vlp) de parvovirus canin (cpv) et utilisations associées
US9913891B2 (en) 2015-11-23 2018-03-13 Merial Inc. FMDV and E2 fusion proteins and uses thereof
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2348709A1 (fr) * 1976-04-23 1977-11-18 Pistor Michel Procede de traitement mesotherapique et dispositif d'injection,formant micro-injecteur automatique,en comportant application
FR2652257B1 (fr) * 1989-09-26 1992-11-27 Rhone Merieux Installation portative de vaccination porcine.
AU650040B2 (en) * 1990-07-24 1994-06-09 Uab Research Foundation, The Methods of use of bovine respiratory syncytial virus recombinant DNA, proteins vaccines, antibodies, and transformed cells
GB9118204D0 (en) * 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
US5643578A (en) * 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
ATE254939T1 (de) * 1993-07-31 2003-12-15 Aradigm Corp Nadelloser injektor
DE69536091D1 (de) * 1994-01-27 2010-09-09 Univ Massachusetts Medical Immunisierung durch Impfung von DNS Transkriptionseinheit
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique

Also Published As

Publication number Publication date
MXPA99000684A (es) 2006-02-10
DE69715879T2 (de) 2003-01-23
FR2751228B1 (fr) 1998-11-20
BR9710498A (pt) 2000-01-18
CA2261334C (en) 2010-11-16
CA2261334A1 (en) 1998-01-29
FR2751228A1 (fr) 1998-01-23
US6803361B2 (en) 2004-10-12
ZA976285B (en) 1999-01-19
US6451770B1 (en) 2002-09-17
WO1998003196A1 (fr) 1998-01-29
DE69715879D1 (de) 2002-10-31
HUP9902792A3 (en) 2000-03-28
AP9701045A0 (en) 1997-07-31
PL331237A1 (en) 1999-07-05
CZ298216B6 (cs) 2007-07-25
HU224833B1 (en) 2006-03-28
PL189184B1 (pl) 2005-07-29
IL127914A (en) 2001-05-20
EP0918540B1 (fr) 2002-09-25
ES2184122T3 (es) 2003-04-01
US20020137716A1 (en) 2002-09-26
AR007863A1 (es) 1999-11-24
CZ10699A3 (cs) 1999-04-14
JP2000515522A (ja) 2000-11-21
ID19427A (id) 1998-07-09
ATE224732T1 (de) 2002-10-15
IL127914A0 (en) 1999-11-30
MA24271A1 (fr) 1998-04-01
EP0918540A1 (fr) 1999-06-02
AU3773297A (en) 1998-02-10
HUP9902792A2 (hu) 1999-12-28
NZ333752A (en) 2000-06-23
AU722878B2 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
CO4700344A1 (es) Vacuna polinucleotidica para bovinos por via intradermica
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
ZA906664B (en) Laser light irradiation apparatus
DE3789716D1 (de) Mechanisch verstärkter Tubus für Heilzwecke.
DE60012711D1 (de) Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
ES2183486T3 (es) Formulaciones de fsh y de variantes de fsh que comprenden alcohol bencilico como agente preservativo.
IT8123867A0 (it) Apparecchio per trapianto artificiale di embrione e ricupero di tessuti.
DE69333610D1 (de) Methoden für die immunoempfängnisverhütung
MX160222A (es) Mejoras en sistema de suministro para apilamiento de panuelos desechables
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
ES2069099T3 (es) Vacuna recombinante para la pleuroneumonia porcina.
KR900011485A (ko) 리오트로픽 액정에 의해 작동되는 분배 장치
ES2061647T3 (es) Vacuna contra el virus de la enfermedad de newcastle y metodo para la aplicacion de la misma.
ES2041338T3 (es) Metodo para la limpieza de objetos y su aparato.
DE69840637D1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
GT199700086A (es) Vacuna polinucleotida para la vacunacion intradermica de los bovinos
ES492195A0 (es) Clavo elastico para la reduccion de fractura de trocanter e implantacion que utiliza este clavo elastico
ECSP972184A (es) Vacuna polinucleotidica destinada a bovinos por via intradermica
AR022662A1 (es) Acidos nucleicos y proteinas del gen mhp3 de mycoplasma hyopneumoniae y sus usos
MX9200288A (es) Procedimiento para la preparacion del acido 1,2,3,4-tetrahidroisoquinolin-3-carboxilico racemico y opticamente activo asi como sus productos previos.
BR8704392A (pt) Equipe dentaria para odontopediatria
PT98867A (pt) Processo para a obtencao de uma sequencia de dna,bacteria recombinante que a contem e metodo para a utilizacao das referidas bacterias para proteccao de plantas
FI910110A0 (fi) I en individuell steril foerpackning foerpackad naol och foer engaongsbruk avsedd spruta med dylik naol.
ES2102836T3 (es) El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.